706.41
price down icon0.81%   -5.79
pre-market  시장 영업 전:  713.48   7.07   +1.00%
loading
전일 마감가:
$712.20
열려 있는:
$712.01
하루 거래량:
348.85K
Relative Volume:
0.90
시가총액:
$43.23B
수익:
$3.06B
순이익/손실:
$1.28B
주가수익비율:
33.17
EPS:
21.2963
순현금흐름:
$447.35M
1주 성능:
-0.24%
1개월 성능:
+4.84%
6개월 성능:
+13.09%
1년 성능:
+36.55%
1일 변동 폭
Value
$697.87
$713.35
1주일 범위
Value
$697.87
$716.62
52주 변동 폭
Value
$510.06
$716.62

알제넥스 NV ADR Stock (ARGX) Company Profile

Name
명칭
Argen X Se Adr
Name
전화
-
Name
주소
-
Name
직원
1,639
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
ARGX's Discussions on Twitter

ARGX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ARGX
Argen X Se Adr
706.41 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
401.00 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.90 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.00 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.04 33.67B 3.81B -644.79M -669.77M -6.24

알제넥스 NV ADR Stock (ARGX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-25 개시 RBC Capital Mkts Outperform
2025-07-08 업그레이드 Deutsche Bank Hold → Buy
2025-07-03 재개 Morgan Stanley Overweight
2025-05-13 업그레이드 Robert W. Baird Neutral → Outperform
2025-03-17 업그레이드 Bernstein Mkt Perform → Outperform
2025-03-12 업그레이드 Deutsche Bank Sell → Hold
2025-01-17 다운그레이드 Deutsche Bank Hold → Sell
2024-11-12 업그레이드 Wolfe Research Peer Perform → Outperform
2024-11-05 업그레이드 Scotiabank Sector Perform → Sector Outperform
2024-11-01 다운그레이드 Robert W. Baird Outperform → Neutral
2024-11-01 업그레이드 William Blair Mkt Perform → Outperform
2024-10-10 재개 Raymond James Strong Buy
2024-10-04 다운그레이드 Deutsche Bank Buy → Hold
2024-08-06 업그레이드 Barclays Equal Weight → Overweight
2024-07-25 업그레이드 Deutsche Bank Hold → Buy
2024-07-23 업그레이드 Oppenheimer Perform → Outperform
2024-02-15 개시 Wolfe Research Peer Perform
2023-12-20 다운그레이드 Deutsche Bank Buy → Hold
2023-12-20 다운그레이드 William Blair Outperform → Mkt Perform
2023-07-31 개시 Scotiabank Sector Perform
2023-07-24 다운그레이드 UBS Buy → Neutral
2023-07-17 재개 Evercore ISI Outperform
2023-06-15 개시 Societe Generale Sell
2023-05-31 개시 UBS Buy
2023-04-25 개시 Citigroup Buy
2023-03-14 업그레이드 Robert W. Baird Neutral → Outperform
2022-12-07 개시 William Blair Outperform
2022-10-12 개시 Oppenheimer Perform
2022-07-29 다운그레이드 Robert W. Baird Outperform → Neutral
2022-06-28 재개 Stifel Buy
2022-05-03 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-12-08 개시 Wells Fargo Overweight
2021-11-29 업그레이드 Piper Sandler Neutral → Overweight
2021-10-29 업그레이드 Guggenheim Neutral → Buy
2021-10-28 업그레이드 Raymond James Outperform → Strong Buy
2021-10-07 개시 Jefferies Buy
2021-09-23 업그레이드 Redburn Neutral → Buy
2021-09-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-07-23 개시 Deutsche Bank Hold
2021-07-19 재개 Wolfe Research Outperform
2021-06-18 개시 UBS Buy
2021-06-04 재개 Robert W. Baird Outperform
2021-05-10 업그레이드 H.C. Wainwright Neutral → Buy
2021-04-23 개시 Redburn Neutral
2021-03-05 재확인 H.C. Wainwright Neutral
2021-02-02 다운그레이드 Piper Sandler Overweight → Neutral
2021-01-04 다운그레이드 Guggenheim Buy → Neutral
2020-08-25 개시 Raymond James Outperform
2020-08-19 다운그레이드 Evercore ISI Outperform → In-line
2020-07-29 개시 H.C. Wainwright Neutral
2020-02-10 개시 BofA/Merrill Buy
2019-11-05 개시 Credit Suisse Neutral
2019-10-31 업그레이드 William Blair Mkt Perform → Outperform
2019-10-22 개시 JP Morgan Overweight
2019-09-27 개시 Wells Fargo Market Perform
2019-09-16 재개 Cowen Outperform
2019-06-28 개시 Robert W. Baird Outperform
2019-01-18 재개 SunTrust Buy
2019-01-04 개시 Morgan Stanley Overweight
2018-12-17 개시 Goldman Buy
2018-12-14 개시 Wolfe Research Outperform
2018-06-29 개시 Nomura Buy
2018-04-09 개시 SunTrust Buy
2018-01-29 재확인 JMP Securities Mkt Outperform
모두보기

알제넥스 NV ADR 주식(ARGX)의 최신 뉴스

pulisher
Aug 27, 2025

Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN

Aug 27, 2025
pulisher
Aug 26, 2025

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded - Investor's Business Daily

Aug 26, 2025
pulisher
Aug 26, 2025

Stocks With Rising Composite Ratings: argenx ADR - MSN

Aug 26, 2025
pulisher
Aug 26, 2025

Stocks With Rising Composite Ratings: Argenx ADR - inkl

Aug 26, 2025
pulisher
Aug 25, 2025

Argenx Tops Buy Point On Bullish Study, 850 Price Target - Investor's Business Daily

Aug 25, 2025
pulisher
Aug 25, 2025

Argenx: study met primary endpoint - AInvest

Aug 25, 2025
pulisher
Aug 25, 2025

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG - GlobeNewswire Inc.

Aug 25, 2025
pulisher
Aug 21, 2025

Argenx Shares Rise 0.42% with $190M Volume Ranking 464th Amid Biotech Sector Surge - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Argenx Q2 2025 reports robust earnings beat - Investing.com

Aug 21, 2025
pulisher
Aug 19, 2025

Argenx's Growth Fuels Strong Demand for Vyvgart; Pipeline Continues to Develop - Morningstar

Aug 19, 2025
pulisher
Aug 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - GlobeNewswire Inc.

Aug 17, 2025
pulisher
Aug 15, 2025

This Stock Ran 31% In A Month. Will Upcoming News Revitalize It? - Investor's Business Daily

Aug 15, 2025
pulisher
Aug 08, 2025

argenx ADR Earns Relative Strength Rating Upgrade; Hits Key Benchmark - inkl

Aug 08, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

argenx ADR earnings beat by $3.26, revenue topped estimates - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 21, 2025
pulisher
Jul 03, 2025

Morgan Stanley assumes coverage on argenx stock with Overweight rating - Investing.com

Jul 03, 2025
pulisher
Jul 01, 2025

Argenx stock advances as H.C. Wainwright reiterates Buy rating - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Argenx stock falls after FDA flags serious risk signal with Vyvgart - Investing.com

Jun 30, 2025
pulisher
May 22, 2025

argenx SE’s SWOT analysis: biotech stock’s growth potential and challenges - Investing.com

May 22, 2025
pulisher
May 20, 2025

argenx ADR Shows Market Leadership With Jump To 84 RS Rating - Investor's Business Daily

May 20, 2025
pulisher
May 14, 2025

10 Stocks Analysts Are Upgrading Today - Insider Monkey

May 14, 2025
pulisher
May 09, 2025

Argenx Earnings: Vyvgart Delivers Strong Sales Growth; Prefilled Syringe Expands Patient Access - Morningstar

May 09, 2025
pulisher
May 09, 2025

Metric Analysis: Argen X SE ADR (ARGX)’s Key Ratios in the Limelight - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

Biotech Tumbles. Why Its Sales Beat Wasn't Enough. - Investor's Business Daily

May 08, 2025
pulisher
May 08, 2025

argenx ADR earnings beat by $0.34, revenue topped estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga

May 08, 2025
pulisher
Apr 30, 2025

Argenx Stock Extends Rally In A Base As Earnings Loom - Investor's Business Daily

Apr 30, 2025
pulisher
Apr 14, 2025

argenx ADR Earns Relative Strength Rating Upgrade - inkl

Apr 14, 2025
pulisher
Apr 12, 2025

Argenx stock target holds at $720, H.C. Wainwright affirms Buy rating By Investing.com - Investing.com South Africa

Apr 12, 2025
pulisher
Apr 11, 2025

Biotech Leader Surges On 'Best-Case Scenario' For Key Drug - Investor's Business Daily

Apr 11, 2025
pulisher
Apr 11, 2025

Guggenheim maintains Buy on Argenx stock, target at $1,100 - Investing.com India

Apr 11, 2025
pulisher
Apr 11, 2025

Guggenheim maintains Buy on Argenx stock, target at $1,100 By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Argenx stock target holds at $720, H.C. Wainwright affirms Buy rating - Investing.com India

Apr 11, 2025
pulisher
Apr 11, 2025

Stifel maintains $780 target on argenx stock after FDA nod - Investing.com

Apr 11, 2025
pulisher
Apr 04, 2025

Stocks To Watch: argenx ADR Sees RS Rating Jump To 91 - Investor's Business Daily

Apr 04, 2025
pulisher
Mar 17, 2025

Bernstein double upgrades Argenx to "outperform," raises price target to €755 By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

Bernstein double upgrades Argenx to "outperform," raises price target to €755 - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Bernstein raises argenx stock rating, hikes target to EUR755 - Investing.com

Mar 17, 2025
pulisher
Mar 13, 2025

TD Cowen maintains argenx stock with $761 target, bullish outlook - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

TD Cowen maintains argenx stock with $761 target, bullish outlook By Investing.com - Investing.com South Africa

Mar 13, 2025

알제넥스 NV ADR (ARGX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
biotechnology ONC
$332.04
price up icon 8.49%
$145.30
price up icon 6.76%
$447.00
price up icon 0.11%
$577.90
price down icon 0.48%
$100.62
price up icon 0.62%
자본화:     |  볼륨(24시간):